Web Results



GenSpera, Inc. (OTC:QB GNSZ) is a development-stage pharmaceutical company based in San Antonio, Texas. The company is focused on therapeutics that ...

Inspyr Therapeutics, Inc. (NSPX)


Inspyr Therapeutics, Inc. Home · About · Technology · Our Prodrugs · Targeting · Oncology · Product Pipeline · Team · Board & Management · Scientific Advisory ...

GenSpera, Inc. | LinkedIn


Learn about working at GenSpera, Inc.. Join LinkedIn today for free. See who you know at GenSpera, Inc., leverage your professional network, and get hired.

GNSZ : Summary for GENSPERA INC - Yahoo Finance


View the basic GNSZ stock chart on Yahoo Finance. Change the date range, chart type and compare GENSPERA INC against other companies.

GNSZ Stock News - GenSpera, Inc. Stock | Seeking Alpha


The best analysis of GNSZ's stock. By the biggest community of pro and individual investors. Includes the bull case, bear case, breaking news.

Genspera Inc - The New York Times


Inspyr Therapeutics Inc. financial and business news, updates, and information from The New York Times and other leading providers.

Inspyr Therapeutics Inc. (NSPX) Stock Message Board - InvestorsHub


GenSpera Inc. (GenSpera) is a development-stage pharmaceutical company. The Company is focused on the development of prodrug cancer therapeutics for  ...

GenSpera, Inc. (@GenSperaNews) | Twitter


GenSpera, Inc. (OTCQB: $GNSZ) is a development stage oncology company focused on therapeutics that deliver a potent, unique & patented drug directly to ...

GenSpera, Inc. - The Chairman's Blog


GenSpera, Inc. GenSpera unlocks conventional thinking to conceive, design, and develop curative cancer therapies that are core to the principles of finding the ...

GenSpera | CrunchBase


GenSpera Inc., a development stage company, focuses on the development of targeted cancer therapeutics for the treatment of cancerous tumors, including ...

Genspera, Inc. (GNSZ) Bulletin Board
0.00 +0.0 (+0.0)
Open: 0.00 High: 0.00
Low: 0.00 Volume: 0
Source: Financial Content
All data is delayed by 15 minutes Disclaimer
More Info

Press Releases :: Inspyr Therapeutics, Inc. (NSPX)


Press Releases. News. Home · News · Press Releases. News. News.

GenSpera Announces Name Change to Inspyr Therapeutics ...


Aug 1, 2016 ... GenSpera, Inc. (OTC/QB: GNSZ), a clinical-stage biotechnology company developing a novel prodrug therapeutic for the treatment of cancer, ...

GenSpera, Inc. | Facebook


2511 N Loop 1604 W, Ste 204. San Antonio, TX 78258 ... GenSpera, Inc. is a development stage oncology company focused on therapeutics that...